BioPorto Diagnostics Employee Directory

BioPorto Diagnostics corporate office is located in 117 4th Ave Ste 202, Needham, Massachusetts, 02494, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

3

Sales

2

Marketing

1

Information Technology

1

Operations

1

Legal

1

Key Employees of BioPorto Diagnostics

  • UF
    United States flag for contact location.
    Ute Feger

    Clinical & Regulatory Affairs Senior Director, Med...

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

BioPorto Diagnostics Global Presence

globalPresence illustration
North America1-10
Europe1-10

Index of contact profiles from BioPorto Diagnostics

Hundreds of professionals searching for BioPorto Diagnostics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at BioPorto Diagnostics

Explore people who held key positions, contributed to BioPorto Diagnostics's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Massachusetts, United States

Frequently Asked Questions Regarding BioPorto Diagnostics Employees

How many employees does BioPorto Diagnostics have?
BioPorto Diagnostics has 11-50 employees
Who are BioPorto Diagnostics key employees?
Some of BioPorto Diagnostics key employees are Ute Feger
Where is BioPorto Diagnostics located?
BioPorto Diagnostics’s headquarters are located at 117 4th Ave Ste 202, Needham, Massachusetts, 02494, United States
How do I contact BioPorto Diagnostics?
BioPorto Diagnostics Contact Info: Phone number: (844) 424-6767 Website: www.bioporto.us
What does BioPorto Diagnostics do?

BioPorto Diagnostics Inc. specializes in innovative solutions for healthcare, specifically focusing on acute kidney injury (AKI) risk assessment through its product ProNephro AKI (NGAL). This product is the first FDA-cleared test for assessing pediatric AKI risk, highlighting the company's commitment to improving patient outcomes. The intended clie... nts include healthcare systems, clinical teams, patients, caregivers, and laboratories. BioPorto aims to revolutionize pediatric kidney care with its range of NGAL products and is set for commercial availability through Roche Diagnostics in 2025.Read More

Is BioPorto Diagnostics a public company?
BioPorto Diagnostics is private company therefore does not currently have an official ticker symbol
See more information about BioPorto Diagnostics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.